ResearcherEssen University HospitalActive in the last 2 years
Hideo Andreas Baba
Matched on ORCID iD 0000-0002-1750-5318; OpenAlex author ID A5052731204. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 28
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). Last author DOI 10.1097/mpa.0000000000002430↗
- Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study. Co-author DOI 10.1016/j.esmoop.2023.102219↗
- Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study. Last author DOI 10.1245/s10434-020-09022-3↗
- Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2021.700315↗
- Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of… Last author DOI 10.1007/s00428-017-2114-2↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiromitsu Hayashi · 3 shared papers, 2021–2025 · strength 0.51
- Paper Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). DOI 10.1097/mpa.0000000000002430↗
- Paper Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2021.700315↗
- Paper Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective S… DOI 10.1245/s10434-020-09022-3↗
- Yosuke Nakao · 2 shared papers, 2021–2025 · strength 0.36
- Takanobu Yamao · 2 shared papers, 2021–2025 · strength 0.36
- Kazuki Matsumura · 2 shared papers, 2021 · strength 0.26
- Yuki Kitano · 1 shared paper, 2025 · strength 0.25
- Kosuke Mima · 1 shared paper, 2025 · strength 0.25
- Shigeki Nakagawa · 1 shared paper, 2025 · strength 0.25
- Toru Takematsu · 1 shared paper, 2025 · strength 0.25
- Georgios A. Kaissis · 1 shared paper, 2024 · strength 0.15
- Julius Keyl · 1 shared paper, 2024 · strength 0.15
- Stefan Kasper · 1 shared paper, 2024 · strength 0.15
- Friederike Jungmann · 1 shared paper, 2024 · strength 0.15
- Timm M. Reißig · 1 shared paper, 2024 · strength 0.15
- Jens Thomas Siveke · 1 shared paper, 2024 · strength 0.15
- Jens Kleesiek · 1 shared paper, 2024 · strength 0.15
- Rickmer Braren · 1 shared paper, 2024 · strength 0.15
- Norio Uemura · 1 shared paper, 2021 · strength 0.15
- Hiroki Sato · 1 shared paper, 2021 · strength 0.15
- Zhao Liu · 1 shared paper, 2021 · strength 0.15
- Masayo Tsukamoto · 1 shared paper, 2021 · strength 0.12
- Akira Chikamoto · 1 shared paper, 2021 · strength 0.12
- Katsunori Imai · 1 shared paper, 2021 · strength 0.12
- Rumi Itoyama · 1 shared paper, 2021 · strength 0.12
- Tatsunori Miyata · 1 shared paper, 2021 · strength 0.12
- Hirohisa Okabe · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.